Accès ouvert
2026
preprint
OpenAlex
G. Prakash, V. Gota, DEEPAK SHARMA, SUPRIYA CHOPRA et autres
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Itay Perlstein, Jonathan M. Meyer, Sharath Kumar, Ziqi Yue et autres
This analysis used pharmacokinetic (PK) modeling to characterize dosing conversions and switching strategies from R064766, a once-every-2-weeks, intramuscular long-acting injectable antipsychotic (LAI) formulation of risperidone microspheres, and RBP-7000, a subcutaneous (sc) LAI formulation of risperidone administered in the abdomen once monthly (q1m), …
us, in, gb, il
(code pays fourni par la source)
2025
review
OpenAlex
Heta N. Shah, Jayashree Veerabhadrappa, Anagha A. Damre, Sharath Kumar et autres
in
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Sharath Kumar, Amit Joshi, Apurva Takke, Diana Grace Varghese et autres
Abstract Introduction Abiraterone acetate has been shown to enhance overall survival and radiographic progression-free survival (rPFS) in men with metastatic castration-resistant prostate cancer (mCRPC). Presently, multiple generic brands of abiraterone are accessible in India. Nevertheless, evidence supporting the clinical equivalence of these …
in
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Abhijith Rajaram Rao, Vanita Noronha, Anant Ramaswamy, Anupa Pillai et autres
ABSTRACT Export Background: Frailty is a significant concern in older patients with cancer, yet there are limited data on frailty and its associated risk factors, particularly in Indian patients. Objectives: The primary objective was to evaluate the occurrence of frailty among older …
in, us
(code pays fourni par la source)
2023
paratext
OpenAlex
Daniel Aaron, Ross Allen Abrams, Mohit Agarwal, Victor Agbafe et autres
us, in, ca, il
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Abhijith Rajaram Rao, Sharath Kumar, Ratan Dhekale, Jyoti Krishnamurthy et autres
Background: Therapeutic decision-making in older patients with cancer is challenging, and there is a need for a clinical parameter that can guide these decisions. The Timed Up and Go (TUG) test is an easy-to-administer tool that measures physical performance and may help …
in
(code pays fourni par la source)